NCT05207969

Brief Summary

This research is about modification during routine cystoscopy (scope in the bladder) procedure \[ experimental research \]. The goal of the study is to evaluate patient experience with cystoscopy by using procedural modification to reduce pain perception. The investigator aim for quality improvement of the current methods of cystoscopy to achieve a better patient experience.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
6 months until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

January 26, 2022

Status Verified

January 1, 2022

Enrollment Period

9 months

First QC Date

June 29, 2021

Last Update Submit

January 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • 1)To determine the efficacy of the act of urination in reducing patient urethral pain during flexible cystoscopy procedure.

    To determine the efficacy of the act of urination , we will use visual analogue score (VAS) , subjective assessment for assessing the patient pain score.

    During cystoscopy procedure

Secondary Outcomes (1)

  • 2)To determine the association between the act of urination with relaxation of external urethral sphincter during flexible cystoscopy procedure.

    During cystoscopy procedure

Study Arms (2)

Control Arm

NO INTERVENTION

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure patient will not giving instruction to urinate during the procedure.

Experimental Arm

EXPERIMENTAL

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure, patient will be ask to urinate and this will lead to contraction of urinary bladder and relaxation of external urethral sphincter. Scope will then pass through external urethral sphinter and go to the urinary bladder

Procedure: Instruction to urinate

Interventions

Cystoscopy procedure will be done based on cystoscopy protocol. During scope procedure, patient will be ask to urinate and this will lead to contraction of urinary bladder and relaxation of external urethral sphincter. Scope will then pass through external urethral sphinter and go to the urinary bladder

Also known as: voiding instruction
Experimental Arm

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age more 18 years old

You may not qualify if:

  • Analgesic use within 24hours
  • History of stricture ,urinary tract infection, existing urethral pain
  • Secondary procedure(exp stent, stone removal, fulguration)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital University Sains Malaysia

Kota Bharu, Kelantan, 15100, Malaysia

RECRUITING

MeSH Terms

Conditions

HematuriaUrinary Bladder NeoplasmsUrinary Bladder CalculiUrologic Diseases

Condition Hierarchy (Ancestors)

Urination DisordersFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUrinary Bladder DiseasesUrinary CalculiUrolithiasisCalculiPathological Conditions, Anatomical

Study Officials

  • MUNAWWAR BIN ADNAN DR, MD

    HUSM

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MUNAWWAR ADNAN DR, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 29, 2021

First Posted

January 26, 2022

Study Start

August 1, 2021

Primary Completion

April 30, 2022

Study Completion

April 30, 2022

Last Updated

January 26, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations